16 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Hive™ Stand-alone Anterior Lumbar Interbody System

FDA 510(k)
FDA Class 2 ·Orthopedic

Anatomic PEEK™ Cervical Fusion System with Nanotechnology

FDA UDI
NANOVIS SPINE, LLC·00814216027887·ANATOMIC PEEK w/ Nano 14 x 11 x 5 x 10°

ELMED

FDA UDI
ELMED INCORPORATED·00842180102736·BIPOLAR RF-CABLE WITH EVEREST / CIRCON INSTRUME...

OsteoMed

FDA UDI
OSTEOMED LLC·00845694053785·Fracture Plate Organizer Block

AGILITY ANKLE REVISION PROSTHESIS

FDA 510(k)
FDA Class 2 ·Orthopedic

SILK NONABSORBABLE SURGICAL SUTURES, USP

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·July 29, 2025

GUIDEWIRE 0.018 4/320CM ANGLED (STRAUB MEDICAL)

FDA Adverse Event
Malfunction ·STRAUB MEDICAL AG·Product code DQX·November 5, 2020

COLLEAGUE PRE P1.7

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·August 11, 2011

OPTICROSS?

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - FREMONT (SUD)·Product code OBJ·October 24, 2014

MECHANICAL WALKER, ROLLATOR

FDA Adverse Event
UNKNOWN·Product code ITJ·July 1, 2013

BD PLATE CAMPYLOBACTER SB 100MM

FDA Adverse Event
Malfunction ·BECTON DICKINSON DE MEXICO·Product code JSJ·June 2, 2022

PEDICLE SCREW MUST COMBINED SETSCREW H4-T27 - (4X)

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code NKB·September 26, 2024

MECTALIF TRANSFORAMINAL CAGES TIPEEK

FDA Adverse Event
Malfunction ·MEDACTA INTERNATIONAL SA·Product code MAX·April 25, 2025

BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal specimens Catalog Number: 444213

FDA Enforcement
Class II ·Terminated·Becton Dickinson & Co.·April 21, 2021

Medrad Continuum MR Infusion system- non-wireless system The MEDRAD Continuum MR Infusion System is designed for patients who require medications and other fluids during an MR procedure. It is intended to provide infusion therapy directly prior to, during and immediately after the MR procedure functioning while either stationary or mobile. It is not intended to provide long-term patient care outside the MR environment. The system is to be used by trained medical staff, primarily critical care, emergency room and radiology nursing staff.

FDA Enforcement
Class II ·Terminated·Bayer Corp·June 11, 2014